Fortaleza Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-23,740
Closed -$1.47M 197
2016
Q2
$1.47M Sell
23,740
-7,045
-23% -$429K 1.2% 39
2016
Q1
$1.76M Hold
30,785
1.11% 42
2015
Q4
$1.82M Sell
30,785
-4,530
-13% -$261K 1.1% 42
2015
Q3
$1.92M Hold
35,315
1.35% 30
2015
Q2
$2.37M Buy
35,315
+2,680
+8% +$175K 1.43% 26
2015
Q1
$1.91M Sell
32,635
-670
-2% -$40.5K 1.08% 34
2014
Q4
$2.18M Hold
33,305
1% 25
2014
Q3
$1.92M Hold
33,305
0.9% 29
2014
Q2
$1.88M Hold
33,305
0.87% 26
2014
Q1
$1.71M Hold
33,305
0.87% 32
2013
Q4
$1.76M Sell
33,305
-2,650
-7% -$130K 0.9% 33
2013
Q3
$1.61M Hold
35,955
0.84% 39
2013
Q2
$1.49M Buy
+35,955
New +$1.57M 0.86% 34

Other funds holding ABBV

Fortaleza Asset Management's ABBV Position: Q3 2016 in Review

Fortaleza Asset Management sold out of AbbVie (ABBV) in Q3 2016, closing a stake of 23,740 shares — an estimated $1.47M sold.

Fortaleza Asset Management first reported a position in ABBV in Q2 2013 and held it in 13 quarters. The position peaked at $2.37M in Q2 2015. 1,654 funds tracked by Wall St. Rank hold ABBV as of Q3 2016.

  • Fortaleza Asset Management reported no remaining AbbVie position as of Q3 2016 after selling out during the quarter.
  • Fortaleza Asset Management sold 23,740 AbbVie shares in Q3 2016, an estimated $1.47M.
  • Fortaleza Asset Management first reported a position in AbbVie in Q2 2013 and held it in 13 quarters.
  • Fortaleza Asset Management's AbbVie position peaked at $2.37M in Q2 2015.
  • 1,654 funds tracked by Wall St. Rank held AbbVie as of Q3 2016.

Based on Fortaleza Asset Management's 13F filing for Q3 2016, filed 14 Nov 2016.